Xortx Therapeutics Inc (XRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 11-2005 | 11-2004 | 11-2003 | 11-2002 | |
| Sales | 679,609 | 459,014 | 333,769 | 252,532 |
| Cost of Goods | 535,315 | 364,385 | 260,710 | 198,758 |
| Gross Profit | 144,294 | 94,629 | 73,059 | 53,774 |
| Operating Expenses | 99,932 | 224,550 | 121,129 | 49,438 |
| Operating Income | 44,677 | -129,536 | -47,360 | 5,094 |
| Interest Expense | 568 | 415 | 0 | 0 |
| Other Income | 1,744 | 1,467 | -209 | -923 |
| Pre-tax Income | 45,853 | -128,484 | -47,569 | 4,171 |
| Income Tax | 3,964 | -6,239 | -11,754 | -791 |
| Net Income Continuous | 41,889 | -122,245 | -35,815 | 4,962 |
| Net Income Discontinuous | 280 | -12,924 | -20,379 | -3,326 |
| Net Income | $42,169 | $-135,169 | $-56,194 | $1,636 |
| EPS Basic Total Ops | 1.49 | -7.43 | -15.07 | 0.88 |
| EPS Basic Continuous Ops | 1.48 | -6.72 | -9.60 | 2.67 |
| EPS Basic Discontinuous Ops | 0.01 | -0.71 | -5.46 | -1.79 |
| EPS Diluted Total Ops | 1.45 | -7.43 | -15.07 | 0.88 |
| EPS Diluted Continuous Ops | 1.44 | -6.72 | -9.60 | 2.67 |
| EPS Diluted Discontinuous Ops | 0.01 | -0.71 | -5.46 | -1.79 |
| EBITDA(a) | $54,589 | $-123,031 | $-42,391 | $9,206 |